NORD urges Congress to remove harmful provision which would gut a key incentive from the 1983 ODA

The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerating therapy development across rare diseases.